Solid Biosciences

SLDB55

$6.32arrow_drop_down9.55%-$0.66

SLDB55

$6.32

arrow_drop_down9.55%-$0.66

Performance History

Key Stats
Open	$6.52
Prev. Close	$6.63
EPS	-3.32
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$255.88M
PE Ratio	-

	LOW	HIGH
Day Range	6.54	7.05
52 Week Range	1.81	15.05

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-3.32

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Solid Biosciences (SLDB)

Solid Biosciences Inc (SLDB) is a biotechnology company that focuses on developing gene therapies for Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle degeneration and weakness. The company's lead product candidate, SGT-001, is a gene therapy that aims to restore functional dystrophin protein expression in patients with DMD. This potential treatment has shown promising results in preclinical studies, and Solid Biosciences is currently conducting clinical trials to evaluate its safety and efficacy in humans.

SLDB stock price history shows that the company's shares have experienced significant volatility over the years. The stock has seen both highs and lows, influenced by various factors such as trial results, regulatory approvals, and market sentiment towards gene therapy companies. Investors should be mindful of the inherent risks associated with investing in biotech stocks, especially those focused on developing novel therapies for rare diseases.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Alexander G. Cumbo
Headquarters: Charlestown
Employees: 87
Exchange: NASDAQ

Keep an eye on Solid Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Solid Biosciences 's (SLDB) price per share?

The current price per share for Solid Biosciences (SLDB) is $6.32. The stock has seen a price change of -$0.67 recently, indicating a -9.56% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Solid Biosciences (SLDB)?

For Solid Biosciences (SLDB), the 52-week high is $15.05, which is 138.13% from the current price. The 52-week low is $1.81, the current price is 249.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Solid Biosciences (SLDB) a growth stock?

Solid Biosciences (SLDB) has shown an average price growth of -1.93% over the past three years. It has received a score of 77 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Solid Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Solid Biosciences (SLDB) stock price performance year to date (YTD)?

As of the latest data, Solid Biosciences (SLDB) has a year-to-date price change of 1.12%. Over the past month, the stock has experienced a price change of -14.36%. Over the last three months, the change has been -29.07%. Over the past six months, the figure is -36.74%. Looking at a longer horizon, the five-year price change stands at -96.57%.

help

Is Solid Biosciences (SLDB) a profitable company?

Solid Biosciences (SLDB) has a net income of -$96.02M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$104.32M. Furthermore, the EBITDA is -$97.67M.

help

What is the market capitalization of Solid Biosciences (SLDB)?

Solid Biosciences (SLDB) has a market capitalization of $255.89M. The average daily trading volume is 6.49, indicating the stock's liquidity and investor engagement.